The effect of glycopyrrolate on postoperative pain and analgesic requirements following laparoscopic sterilisation.
In order to evaluate the contribution of tubal spasm to pelvic pain following laparoscopic sterilisation, we have studied the effect of glycopyrrolate, an anticholinergic agent with antispasmodic properties, on 60 ASA 1 and 2 patients presenting as day-cases for laparoscopic sterilisation using Filshie clips. In a randomised, double-blind, controlled trial, patients received either glycopyrrolate 0.3 mg or saline intravenously prior to induction of anaesthesia. Compared with the control group, patients receiving glycopyrrolate had significantly reduced immediate postoperative pain scores (p < 0.02) and required significantly less postoperative morphine (p < 0.01). Nausea, vomiting and anti-emetic requirements were also reduced though not significantly. We conclude that glycopyrrolate 0.3 mg at induction of anaesthesia is an effective method of improving the quality of recovery after day-case laparoscopic sterilisation using clips.
Guard
B C
BC
Department of Anaesthesia, Ipswich Hospital, Suffolk.
Wiltshire
S J
SJ
D000328:Adult; D000556:Ambulatory Surgical Procedures; D000701:Analgesics, Opioid / Q000008:administration & dosage; D004311:Double-Blind Method; D005260:Female; D006024:Glycopyrrolate / Q000627:therapeutic use*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects*; D009020:Morphine / Q000008:administration & dosage; D010149:Postoperative Pain / Q000209:etiology / Q000517:prevention & control*; D010276:Parasympatholytics / Q000627:therapeutic use*; D011229:Preanesthetic Medication; D013246:Sterilization, Tubal / Q000009:adverse effects*
D000701:Analgesics, Opioid; D010276:Parasympatholytics; D009020:Morphine; D006024:Glycopyrrolate